Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4108.TW Stock Summary
Top 10 Correlated ETFs
4108.TW
In the News
4108.TW Financial details
Company Rating
Sell
Market Cap
4.09B
Income
-50.4M
Revenue
162.49M
Book val./share
9.7
Cash/share
6.37
Dividend
-
Dividend %
-
Employees
84
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-82.35
Forward P/E
-
PEG
13.33
P/S
29.19
P/B
2.78
P/C
3.27
P/FCF
-69.12
Quick Ratio
25.47
Current Ratio
28.9
Debt / Equity
0.01
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.26
EPS next Y
-
EPS next Q
-
EPS this Y
-44.12%
EPS next Y
-
EPS next 5Y
183.49%
EPS last 5Y
-17.76%
Revenue last 5Y
11.22%
Revenue Q/Q
7.1%
EPS Q/Q
-700%
-
-
-
-
SMA20
-4.55%
SMA50
-4.55%
SMA100
5%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-3%
ROC
-0.04%
Gross Margin
42%
Oper. Margin
-59%
Profit Margin
-43%
Payout
-
Shs Outstand
198.62M
Shs Float
161.32M
-
-
-
-
Target Price
-
52W Range
18.6-25.25
52W High
-16.8%
52W Low
+15.56%
RSI
41
Rel Volume
1.6
Avg Volume
370.45K
Volume
591.77K
Perf Week
0.73%
Perf Month
-4.59%
Perf Quarter
5.58%
Perf Half Y
4.52%
-
-
-
-
Beta
1.012
-
-
Volatility
0.14%, 0.82%
Prev Close
1.46%
Price
20.8
Change
2.46%
4108.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.57 | 0.56 | 0.86 | 0.8 | 0.83 | |
Net income per share | -1.01 | -0.73 | -0.4 | -0.68 | -0.38 | |
Operating cash flow per share | -0.72 | -0.9 | -0.35 | -0.36 | -0.28 | |
Free cash flow per share | -0.76 | -0.91 | -0.42 | -0.36 | -0.3 | |
Cash per share | 4.47 | 4.64 | 7.23 | 8.07 | 6.45 | |
Book value per share | 7.72 | 7.85 | 10.12 | 11.31 | 9.82 | |
Tangible book value per share | 9.75 | 9.8 | 11.75 | 13.02 | 11.19 | |
Share holders equity per share | 7.72 | 7.85 | 10.12 | 11.31 | 9.82 | |
Interest debt per share | 0.1 | 0.11 | 0.16 | 0.18 | 0.14 | |
Market cap | 3.04B | 4.01B | 4.56B | 3.22B | 4.26B | |
Enterprise value | 2.94B | 3.97B | 4.5B | 3.15B | 4.23B | |
P/E ratio | -17.77 | -33.84 | -58.44 | -28.01 | -57.46 | |
Price to sales ratio | 31.8 | 43.73 | 26.99 | 23.79 | 26.22 | |
POCF ratio | -25 | -27.15 | -66.82 | -53.75 | -77.78 | |
PFCF ratio | -23.64 | -26.87 | -55.98 | -52.35 | -71.6 | |
P/B Ratio | 2.33 | 3.13 | 2.3 | 1.69 | 2.21 | |
PTB ratio | 2.33 | 3.13 | 2.3 | 1.69 | 2.21 | |
EV to sales | 30.81 | 43.25 | 26.62 | 23.27 | 26 | |
Enterprise value over EBITDA | -21.09 | -65.06 | -106.07 | -50.82 | -204.15 | |
EV to operating cash flow | -24.23 | -26.85 | -65.9 | -52.58 | -77.15 | |
EV to free cash flow | -22.9 | -26.58 | -55.21 | -51.21 | -71.01 | |
Earnings yield | -0.06 | -0.03 | -0.02 | -0.04 | -0.02 | |
Free cash flow yield | -0.04 | -0.04 | -0.02 | -0.02 | -0.01 | |
Debt to equity | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | 0.68 | 0.72 | 1.49 | 1.13 | 1.67 | |
Current ratio | 9.12 | 12.44 | 28.78 | 25.25 | 26.13 | |
Interest coverage | -763.4 | -483 | -235.09 | -366.86 | -353.71 | |
Income quality | 0.59 | 1.27 | 0.71 | 0.52 | 0.74 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.85 | 0.67 | 0.37 | 0.45 | 0.38 | |
Research and developement to revenue | 1.72 | 1.36 | 0.71 | 0.88 | 0.57 | |
Intangibles to total assets | 0.06 | 0.05 | 0.04 | 0.03 | 0.03 | |
Capex to operating cash flow | 0.06 | 0.01 | 0.19 | 0.03 | 0.09 | |
Capex to revenue | -0.07 | -0.02 | -0.08 | -0.01 | -0.03 | |
Capex to depreciation | -0.11 | -0.03 | -0.25 | -0.03 | -0.09 | |
Stock based compensation to revenue | 0.01 | 0 | 0.04 | 0.01 | 0.01 | |
Graham number | 13.27 | 11.31 | 9.53 | 13.17 | 9.13 | |
ROIC | -0.13 | -0.09 | -0.04 | -0.06 | -0.1 | |
Return on tangible assets | -0.1 | -0.07 | -0.03 | -0.05 | -0.03 | |
Graham Net | 4.26 | 4.69 | 7.4 | 8.25 | 6.72 | |
Working capital | 819.3M | 886.03M | 1.56B | 1.51B | 1.44B | |
Tangible asset value | 1.65B | 1.6B | 2.3B | 2.2B | 2.2B | |
Net current asset value | 790M | 855.98M | 1.54B | 1.48B | 1.42B | |
Invested capital | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
Average receivables | 49.56M | 47.05M | 54.23M | 56.48M | 62.74M | |
Average payables | 2.29M | 3.15M | 2.92M | 3.76M | 3.99M | |
Average inventory | 109.85M | 137.05M | 148.59M | 148.42M | 157.16M | |
Days sales outstanding | 162.81 | 204.8 | 123.03 | 150.92 | 156.06 | |
Days payables outstanding | 27.24 | 30.85 | 7.73 | 26.09 | 9.17 | |
Days of inventory on hand | 1.4K | 1.19K | 586.51 | 703.74 | 627.63 | |
Receivables turnover | 2.24 | 1.78 | 2.97 | 2.42 | 2.34 | |
Payables turnover | 13.4 | 11.83 | 47.22 | 13.99 | 39.8 | |
Inventory turnover | 0.26 | 0.31 | 0.62 | 0.52 | 0.58 | |
ROE | -0.13 | -0.09 | -0.04 | -0.06 | -0.04 | |
Capex per share | -0.04 | -0.01 | -0.07 | -0.01 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.17 | 0.18 | 0.18 | 0.18 | 0.23 | |
Net income per share | -0.25 | -0.04 | -0.07 | 0.03 | -0.18 | |
Operating cash flow per share | -0.05 | -0.18 | -0.09 | 0.01 | -0.03 | |
Free cash flow per share | -0.05 | -0.18 | -0.1 | 0.01 | -0.03 | |
Cash per share | 6.85 | 7.28 | 5.93 | 5.24 | 6.37 | |
Book value per share | 9.61 | 10.27 | 9.08 | 7.91 | 9.7 | |
Tangible book value per share | 11.06 | 11.79 | 10.37 | 9.02 | 11.06 | |
Share holders equity per share | 9.61 | 10.27 | 9.08 | 7.91 | 9.7 | |
Interest debt per share | 0.15 | 0.15 | 0.12 | 0.13 | 0.14 | |
Market cap | 3.79B | 3.5B | 5.05B | 4.86B | 4.31B | |
Enterprise value | 3.72B | 3.44B | 5.01B | 4.84B | 4.28B | |
P/E ratio | -19.08 | -117.81 | -83.75 | 166.67 | -30.61 | |
Price to sales ratio | 112.19 | 106.2 | 128.04 | 111.69 | 92.48 | |
POCF ratio | -383.16 | -107.04 | -261.98 | 1.42K | -691.15 | |
PFCF ratio | -357.05 | -101.9 | -245.58 | 2.11K | -624.01 | |
P/B Ratio | 1.99 | 1.84 | 2.58 | 2.53 | 2.24 | |
PTB ratio | 1.99 | 1.84 | 2.58 | 2.53 | 2.24 | |
EV to sales | 110.11 | 104.39 | 127.24 | 111.31 | 91.74 | |
Enterprise value over EBITDA | -102 | -1.31K | -548.61 | 376.93 | -196.24 | |
EV to operating cash flow | -376.06 | -105.22 | -260.35 | 1.41K | -685.6 | |
EV to free cash flow | -350.43 | -100.17 | -244.05 | 2.1K | -618.99 | |
Earnings yield | -0.01 | 0 | 0 | 0 | -0.01 | |
Free cash flow yield | 0 | -0.01 | 0 | 0 | 0 | |
Debt to equity | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | 1.92 | 22.69 | 3.45 | -1.28 | 1.59 | |
Current ratio | 25.25 | 30.49 | 26.29 | 28.9 | 26.13 | |
Interest coverage | -729.1 | -188.23 | -291.03 | -5.29 | -454.29 | |
Income quality | 0.2 | 2.06 | 0.86 | -6.05 | 0.18 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.46 | 0.42 | 0.41 | 0.35 | 0.34 | |
Research and developement to revenue | 1.3 | 0.42 | 0.51 | 0.5 | 0.78 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | 0.07 | 0.05 | 0.07 | -0.33 | 0.11 | |
Capex to revenue | -0.02 | -0.05 | -0.03 | -0.03 | -0.01 | |
Capex to depreciation | -0.06 | -0.12 | -0.1 | -0.08 | -0.05 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0.02 | 0 | |
Graham number | 7.36 | 3.04 | 3.78 | 2.31 | 6.22 | |
ROIC | -0.03 | 0 | -0.01 | 0 | -0.03 | |
Return on tangible assets | -0.02 | 0 | -0.01 | 0 | -0.02 | |
Graham Net | 7 | 7.58 | 6.21 | 5.5 | 6.65 | |
Working capital | 1.51B | 1.53B | 1.46B | 1.47B | 1.44B | |
Tangible asset value | 2.2B | 2.19B | 2.23B | 2.19B | 2.2B | |
Net current asset value | 1.48B | 1.51B | 1.44B | 1.44B | 1.42B | |
Invested capital | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
Average receivables | 56.41M | 58.34M | 66.8M | 69.68M | 67.95M | |
Average payables | 6.26M | 5.67M | 5.55M | 4M | 2.51M | |
Average inventory | 155.56M | 158.66M | 167.34M | 174.31M | 171.56M | |
Days sales outstanding | 149.08 | 165.63 | 166.57 | 137.4 | 134.16 | |
Days payables outstanding | 25.78 | 26.12 | 20.98 | 9.58 | 7.87 | |
Days of inventory on hand | 695.39 | 755.45 | 659.91 | 652.53 | 538.94 | |
Receivables turnover | 0.6 | 0.54 | 0.54 | 0.66 | 0.67 | |
Payables turnover | 3.49 | 3.45 | 4.29 | 9.4 | 11.43 | |
Inventory turnover | 0.13 | 0.12 | 0.14 | 0.14 | 0.17 | |
ROE | -0.03 | 0 | -0.01 | 0 | -0.02 | |
Capex per share | 0 | -0.01 | -0.01 | 0 | 0 |
4108.TW Frequently Asked Questions
What is PhytoHealth Corporation stock symbol ?
PhytoHealth Corporation is a TW stock and trading under the symbol 4108.TW
What is PhytoHealth Corporation stock quote today ?
PhytoHealth Corporation stock price is $20.8 today.
Is PhytoHealth Corporation stock public?
Yes, PhytoHealth Corporation is a publicly traded company.